Endovascular Engineering, Inc., is a mission driven, venture-backed company focusing on the development and deployment of groundbreaking clot removal technologies that target venous thromboembolism.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/13/26 | $80,000,000 | Series C |
415 Ventures Gilde Healthcare Partners ![]() M&L Healthcare Investments Norwest Venture Partners Panakes S3 Ventures Sante Ventures | undisclosed |